ArticleOncotarget2016
The novel VEGF receptor 2 inhibitor YLL545 inhibits angiogenesis and growth in breast cancer.
Jianbo Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticleOncotarget2016
Jianbo Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.